Inogen
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 834
- Market Cap
- -
- Introduction
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers
- Conditions
- Cognition
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Inogen Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06555484
- Locations
- 🇺🇸
Two Liberty Place, Philadelphia, Pennsylvania, United States
Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia
- Conditions
- Nocturnal Hypoxemia
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Inogen Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06000332
- Locations
- 🇺🇸
Piedmont Healthcare, Statesville, North Carolina, United States
Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure
- Conditions
- Heart Failure
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Inogen Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05719363
- Locations
- 🇨🇦
Montreal Heart Institute, Montréal, Quebec, Canada
Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study.
- Conditions
- COVID-19
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Inogen Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT05212831
- Locations
- 🇨🇦
Montreal Heart Institute, Montréal, Quebec, Canada
🇨🇦Centre ÉPIC de l'Institut de cardiologie de Montréal, Montréal, Quebec, Canada